WO2023002409 - COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CORONAVIRAL RELATED DISEASES
National phase entry:
Publication Number
WO/2023/002409
Publication Date
26.01.2023
International Application No.
PCT/IB2022/056712
International Filing Date
20.07.2022
Title **
[English]
COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CORONAVIRAL RELATED DISEASES
[French]
COMPOSÉS ET COMPOSITIONS POUR LE TRAITEMENT DE MALADIES ASSOCIÉES AU CORONAVIRUS
Applicants **
NOVARTIS AG
Inventors
BAO, Denghui
GUO, Fengfeng
HESSE, Matthew James
HORNAK, Viktor
JOSEPH, Sajan
KIRRANE JR., Thomas Martin
LIU, Bo
LIN, Haiyao
MIAO, Yanan
MOSER, Heinz Ernst
PAPILLON, Julien
QU, Yang
SHI, Lei
YUAN, Jun
ZHANG, Teng
Priority Data
63/224,793
22.07.2021
US
63/289,009
13.12.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 6511 | |
| EPO | Filing, Examination, Granting | 62367 | |
| Japan | Filing, Examination, Granting | 3931 | |
| South Korea | Filing, Examination, Granting | 5510 | |
| USA | Filing, Examination, Granting | 44040 |
Total:
122,359
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Provided herein are compounds and compositions for treating, managing or preventing coronaviral related diseases. In particular, provided herein are compounds which are inhibitors of SARS-CoV-2 main protease (Mpro), pharmaceutical compositions comprising such compounds, method for synthesizing such compounds and methods of using such compounds and compositions for the treatment, management or prevention of coronaviral related diseases.[French]
L'invention concerne des composés et des compositions pour le traitement, la gestion ou la prévention de maladies associées au coronavirus. En particulier, l'invention concerne des composés qui sont des inhibiteurs de la protéase principale du SARS-CoV-2 (Mpro), des compositions pharmaceutiques comprenant de tels composés, un procédé de synthèse de tels composés et des procédés d'utilisation de ces composés et de ces compositions pour le traitement, la gestion ou la prévention de maladies associées au coronavirus.